Soleno Therapeutics, Inc. (SLNO) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 2.46B |
| Enterprise Value | 2.39B |
| P/E Ratio | 27.09 |
| PEG Ratio | 0.02 |
| Price/Sales Ratio | 9.69 |
| Price/Book Ratio | 5.57 |
| Enterprise/Revenue | 9.24 |
| Enterprise/EBITDA | 24.62 |
Fiscal Year
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | March 31, 2026 |
Profitability
| Profit Margin | 0.34 |
| Operating Margin | 0.31 |
AD
Management Effectiveness
| Return On Assets | 0.16 |
| Return On Equity | 0.23 |
Income Statement
| Revenue | 190.41M |
| Revenue/Share | 5.47 |
| Gross Profit | 187.71M |
| EBITDA | 28.38M |
| Net Income | 20.89M |
| Diluted EPS | 0.39 |
Balance Sheet
| Total Cash | 255.6M |
| Total Cash/Share | 4.91 |
| Total Debt | 4.41M |
| Total Debt/Equity | 0.01 |
| Current Ratio | 5.62 |
| Book Value Per Share | 9.52 |
Price History
| 52-Week Change | -32.17 |
| 52-Week High | 90.32 |
| 52-Week Low | 29.43 |
| Moving Average 50 Days | 45.78 |
| Moving Average 200 Days | 51.16 |
Statistics
| Average Volume | 3.45M |
| Shares Outstanding | 52.12M |
| % Held by Institutions | 119.7 |
Dividend And Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | 1:15 |
| Last Split Date | August 26, 2022 |
AD
